Citius Pharmaceuticals Inc (CTXR) has gained Thursday morning, with the stock increasing 1.97% in pre-market trading to 2.07. CTXR's short-term technical score of 39 indicates that the stock has traded less bullishly over the last month than 61% of stocks on the market. In the Biotechnology industry, which ranks 134 out of 146 industries, CTXR ranks higher than 68% of stocks. Citius Pharmaceuticals Inc has fallen 3.33% over the past month, closing at $2.10 on September 9. During this period of time, the stock fell as low as $1.95 and as high as $2.20. CTXR has an average analyst recommendation of Strong Buy. The company has an average price target of $7.00.
CTXR has an Overall Score of 52. Find out what this means to you and get the rest of the rankings on CTXR!